Kristin Abate - Chief Accounting Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kristin Abate since 4/23/2024

Holdings reported by Kristin Abate for Karyopharm Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 9.71K $6.12K $0.63 Mar 4, 2025 Direct
Stock Option (right to buy) 1.87K Feb 28, 2025 Direct Common Stock

Transactions reported by Kristin Abate for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.